TheProfitWatch

NKTR - Nektar Therapeutics

Day 1m 10m 60m PreMarket Market AfterHours Gap
55.05 -0.73 (-1.34%) -0.05 (-0.08%) -0.12 (-0.22%) -0.55 (-1.01%) 0.37 (0.67%) -0.98 (-1.78%) 0.32 (0.58%) 0.26 (0.47%)

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-2.95
Diluted EPS:
-2.95
Basic P/E:
-18.4119
Diluted P/E:
-18.4119
RSI(14) 1m:
48.68
VWAP:
54.32
RVol:

Events

Period Kind Movement Occurred At

Related News